Semaglutide, sold under the name Ozempic, Vegovy or Rybelsus, belongs to the pharmacological class of GLP-1 (glucagon-like peptide-1) analogues, which work by mimicking the natural hormones called incretins, responsible for initiating insulin production after meal as well as reducing appetite and slowing the food digestion
GLP-1(936)s glucagonostatic effect operates in parallel with that of GLP-1(736), as illustrated schematically in Fig
However, real-world data shows conflicting persistence trends, with one study revealing that 63% of patients persist for at least one year, while another shows that one-third of people stopped taking their GLP-1 in the first month, and less than half stayed on for more than 12 weeks
10.1016/s0140-6736(09)60659-0 14 CampbellJ
Packaging is the first thing to check